Arbutus Biopharma Corporation logo
Arbutus Biopharma Corporation ABUS
$ 4.15 -3.49%

Annual report 2025
added 03-23-2026

report update icon

Arbutus Biopharma Corporation P/S Ratio 2011-2026 | ABUS

Annual P/S Ratio Arbutus Biopharma Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
60.1 133 24.5 10.8 37.6 43.5 26.5 34.5 26 90.7 5.74 38.4 12.9 4.68 1.49

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
133 1.49 36.7

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Nanobiotix S.A. Nanobiotix S.A.
NBTX
98.9 K $ 30.34 -0.82 % $ 286 B franceFrance
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Applied Therapeutics Applied Therapeutics
APLT
54.1 - - $ 8.42 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 95.5 3.83 % $ 27.2 B germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
759 $ 2.92 -0.34 % $ 6.35 B israelIsrael
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.73 $ 20.37 -2.4 % $ 952 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.32 K $ 32.24 -4.1 % $ 2.14 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
1.42 $ 1.4 -0.71 % $ 360 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
Aptinyx Aptinyx
APTX
204 - -39.0 % $ 4.57 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
10.5 $ 4.08 -2.16 % $ 436 M usaUSA
Aravive Aravive
ARAV
6.61 - -13.39 % $ 1.45 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
9.15 $ 24.21 -1.47 % $ 3.08 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.27 $ 1.49 1.36 % $ 397 M britainBritain
Cidara Therapeutics Cidara Therapeutics
CDTX
116 - - $ 1.41 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
11.2 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
0.237 $ 2.55 -0.78 % $ 16 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
2.17 - - $ 96.9 B britainBritain
Immutep Limited Immutep Limited
IMMP
492 $ 0.31 -2.52 % $ 1.08 B australiaAustralia
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
BeiGene, Ltd. BeiGene, Ltd.
BGNE
66.4 - 0.49 % $ 251 B cayman-islandsCayman-islands
Evogene Ltd. Evogene Ltd.
EVGN
71.3 $ 0.81 -1.16 % $ 27.9 M israelIsrael
Baudax Bio Baudax Bio
BXRX
0.614 - 0.59 % $ 63 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.3 M $ 3.13 -1.26 % $ 315 M usaUSA